Skip to main content

Windward Bio Group AG

WWB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002145089

In the last 90 days, Windward Bio Group AG insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.

Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)

No financial statements

Windward Bio Group AG has no financial statements on Livermore. They come from the XBRL data in 10-K, 10-Q, 20-F and 40-F filings, so ETFs, funds and companies that don't file these reports have none.